Displaying 11 - 20 of 324
Image
CAR T-cell therapy and stem cell transplantation in Canada: Medical expertise and lived experience
Updated:
In partnership with Cell Therapy Transplant Canada (CTTC), The Leukemia & Lymphoma Society of Canada (LLSC) is pleased to provide this special, 90-minute webcast on the latest innovations in blood cancer treatment in Canada.
Treatment and side effects
Image
Myelodysplastic syndromes (MDS)
Updated:
Myelodysplastic syndromes are a group of cancers of the blood and bone marrow. With an MDS, your bone marrow – the soft, spongy material inside your bones – does not produce enough healthy blood cells.
Myelodysplastic syndromes
Image
“I'm still here": Living with multiple myeloma for 12 years
Updated:
David Johnson, of BC, first diagnosed with the disease in 2012 in his early 50s, has experienced 2 relapses, 2 stem cell transplants, and participated in a clinical trial for CAR T-cell therapy. Dr. Anthony Reiman, medical oncologist in NB, talks about advances in MM treatment.
Myeloma
Image
Managing Graft vs Host Disease (GvHD): Guide for Healthcare Professionals
Updated:
This fact sheet provides an overview of GvHD for healthcare professionals. It reviews presenting symptoms, treatment options and side effects to effectively support your patients.
Treatment and side effects
Image
Acute Myeloid Leukemia (AML)
Updated:
AML is one of four main types of leukemia. It progresses quickly if untreated. It features cancerous blood cells, often called “blasts.” AML typically affects adults over the age of 65 and is slightly more common in men.
Leukemia
Image
Angioimmunoblastic T-cell Lymphoma (AITL)
Updated:
AITL is a rare, fast-growing (aggressive) T-cell subtype of non-Hodgkin lymphoma (NHL) and a common subtype of peripheral T-cell lymphoma (PTCL). AITL typically affects adults over 50.
Lymphoma
Image
How to actively participate in you cancer care (self advocacy): 2024 Leukemia Conference
Updated:
Learn practical ways to be a proactive agent of change in your own cancer experience or that of your loved one. This webcast was led by Geoffrey Molle and Natasha Sani, from the Community Services Team at LLSC, and will include people impacted by blood cancer. They will offer…
Leukemia
Image
Acute myeloid leukemia (AML): Expanding access to novel treatment and care, 2024 Leukemia Conference
Updated:
Acute myeloid leukemia (AML) is a type of cancer that forms in blood cells and bone marrow that progresses rapidly if untreated. In this presentation, Dr. Brett Houston, a hematologist at the University of Manitoba, will speak about her work in clinical trials in finding ways to…
Leukemia
Image
Acute lymphoblastic leukemia (ALL): Changing treatment goals - 2024 Leukemia Conference, LLSC
Updated:
Acute lymphoblastic leukemia (ALL) affects immature white blood cells called lymphoblasts and can progresses quickly without treatment. Dr. Dawn Maze, a member of the Leukemia Program and the Elizabeth and Tony Comper MPN Program at the Princess Margaret Cancer Centre, addresses…
Leukemia
Image
Understanding ribonucleic acid (RNA) and its role in leukemia: 2024 Leukemia Conference
Updated:
RNA is more than just DNA's lesser-known cousin. Dr. Katherine Borden, Professor, Pathology, Cell Biology at the Institute for Research in Immunology and Cancer, University of Montreal and Dr. Sarit Assouline, chief of the Division of Hematology at the JGH and Senior…
Leukemia